• Profile
Close

Single dose moxidectin vs ivermectin for Onchocerca volvulus infection in Ghana, Liberia, and the Democratic Republic of the Congo: A randomised, controlled, double-blind phase 3 trial

The Lancet Jan 31, 2018

Opoku NO, et al. - During this study, authors undertook a comparative assessment of the parasitological efficacy and safety of moxidectin and ivermectin for the treatment of Onchocerca volvulus infection. Data disclosed lower skin microfilarial loads (ie, parasite transmission reservoir) following moxidectin treatment when compared to ivermectin treatment. Hence, moxidectin would aid in reducing the parasite transmission between treatment rounds more than ivermectin could, thereby accelerating progress towards elimination.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay